Cite
HARVARD Citation
Modest, D. et al. (2022). FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314). European journal of cancer. pp. 297-306. [Online].